Lab tools & diagnostics
Instruments, supplies and testing services for labs, drugmakers and doctors.
Gegroepeerd met hulp van een AI-model en nagekeken door onze redactie. De regel onder elk bedrijf zegt waarom het hier staat.
Aandelenkoersen zijn de slotkoersen van 11 nov 2026, uit de IEX-beursfeed.
Grade mix
A 8B 8C 2D 1F 1
Revenue growing
19 of 20
Free cash flow growing
9 of 20
Median price move, 1 year
+22,0%
TMOTHERMO FISHER SCIENTIFIC INC.Diagnostics and researchMarket cap US$ 265,9BP/E 37,85
US$ 717,62+22,5%1YSince added +8,2%
A+- Groei en kasstroom
- Groeit sterk
- Business trend
- Versnellend
- Business quality
- Sterk
- Getting better
- Verbetert
Revenue
US$ 47,4B+8,3%Profit
US$ 7,1B+7,6%Free cash flow
US$ 7,6B+24,3%Why it is here: Sells lab instruments, reagents and services to researchers and drug makers
DHRDANAHER CORPORATIONDiagnostics and researchMarket cap US$ 165,5BP/E 38,51
US$ 235,31+8,0%1YSince added +5,4%
B+- Groei en kasstroom
- Groeit sterk
- Business trend
- Versnellend
- Business quality
- Sterk
- Getting better
- Verbetert
Revenue
US$ 25,6B+5,5%Profit
US$ 4,3B+23,6%Free cash flow
US$ 5,7B+14,2%Why it is here: Sells research instruments, supplies and services
AAGILENT TECHNOLOGIES, INC.Diagnostics and researchMarket cap US$ 49,9BP/E 34,89
US$ 176,91+17,6%1YSince added +3,1%
B+- Groei en kasstroom
- Groeit sterk
- Business trend
- Versnellend
- Business quality
- Sterk
- Getting better
- Verbetert
Revenue
US$ 7,4B+8,6%Profit
US$ 1,4B+18,0%Free cash flow
US$ 1,3B+16,5%Why it is here: Sells lab instruments, consumables and software to labs and drug makers
WATWaters CorporationDiagnostics and researchMarket cap US$ 46,3BP/E 202,08
US$ 470,84+21,5%1YSince added +9,7%
D- Groei en kasstroom
- Groeit
- Business trend
- Vertragend
- Business quality
- Gemengd
- Getting better
- Gemengd
Revenue
US$ 5,6B+84,2%Profit
US$ 98,6M-84,8%Free cash flow
US$ 290,8M-51,7%Why it is here: Sells liquid chromatography and mass spectrometry instruments and consumables
MTDMettler-Toledo International Inc.Diagnostics and researchMarket cap US$ 34,8BP/E 37,95
US$ 1.749,30+20,8%1YSince added +9,4%
B+- Groei en kasstroom
- Groeit sterk
- Business trend
- Stabiel
- Business quality
- Sterk
- Getting better
- Verbetert
Revenue
US$ 4,2B+6,5%Profit
US$ 934,1M+11,8%Free cash flow
US$ 870,6M-2,1%Why it is here: Makes precision laboratory instruments and weighing equipment
ILMNIllumina, Inc.Diagnostics and researchMarket cap US$ 32,2BP/E 36,64
US$ 212,86+74,5%1YSince added -21,5%
A+- Groei en kasstroom
- Groeit sterk
- Business trend
- Stabiel
- Business quality
- Sterk
- Getting better
- Verbetert sterk
Revenue
US$ 4,5B+5,8%Profit
US$ 895M+27,5%Free cash flow
US$ 1,1B+5,7%Why it is here: Sells DNA sequencing instruments and reagents
IDXXIDEXX LABORATORIES INC /DEDiagnostics and researchMarket cap US$ 55,4BP/E 47,37
US$ 703,00-1,5%1YSince added +35,2%
A+- Groei en kasstroom
- Groeit sterk
- Business trend
- Stabiel
- Business quality
- Sterk
- Getting better
- Verbetert sterk
Revenue
US$ 4,7B+11,9%Profit
US$ 1,2B+15,1%Free cash flow
US$ 1,3B+35,3%Why it is here: Sells veterinary diagnostic tests and instruments
DGXQuest Diagnostics IncDiagnostics and researchMarket cap US$ 28,5BP/E 25,77
US$ 258,72+40,8%1YSince added +12,2%
A- Groei en kasstroom
- Groeit sterk
- Business trend
- Stabiel
- Business quality
- Solide
- Getting better
- Verbetert
Revenue
US$ 11,8B+9,1%Profit
US$ 1,1B+16,5%Free cash flow
US$ 1,4B-1,3%Why it is here: Provides diagnostic testing and clinical lab services
LHLABCORP HOLDINGS INC.Diagnostics and researchMarket cap US$ 30,2BP/E 30,53
US$ 372,18+41,3%1YSince added +18,7%
A- Groei en kasstroom
- Groeit sterk
- Business trend
- Stabiel
- Business quality
- Gemengd
- Getting better
- Verbetert sterk
Revenue
US$ 14,6B+6,0%Profit
US$ 1B+17,4%Free cash flow
US$ 1,3B-6,8%Why it is here: Provides diagnostic tests and clinical lab services
RVTYREVVITY, INCDiagnostics and researchMarket cap US$ 17,7BP/E 70,32
US$ 158,22+68,5%1YSince added +2,0%
A- Groei en kasstroom
- Groeit sterk
- Business trend
- Stabiel
- Business quality
- Gemengd
- Getting better
- Verbetert
Revenue
US$ 2,9B+4,6%Profit
US$ 253,2M+6,6%Free cash flow
US$ 590,5M+18,7%Why it is here: Sells lab instruments, reagents and diagnostics tools to research and drug makers
IQVIQVIA HOLDINGS INC.Diagnostics and researchMarket cap US$ 45,2BP/E 33,38
US$ 274,37+24,2%1YSince added +5,2%
A- Groei en kasstroom
- Groeit sterk
- Business trend
- Stabiel
- Business quality
- Gemengd
- Getting better
- Verbetert
Revenue
US$ 17,3B+8,8%Profit
US$ 1,4B+8,7%Free cash flow
US$ 2,1B-6,0%Why it is here: Runs clinical trials and sells healthcare data to drugmakers
NTRANATERA, INC.Diagnostics and researchMarket cap US$ 46,4BGeen K/W (bedrijfsverlies)
US$ 319,77+52,6%1YSince added -19,2%
B-- Groei en kasstroom
- Groeit sterk
- Business trend
- Stabiel
- Business quality
- Zwak
- Getting better
- Gemengd
Revenue
US$ 2,9B+37,4%Profit
US$ -164,7M+46,7%Free cash flow
US$ 52,5M-50,5%Why it is here: Provides genetic and cell-free DNA diagnostic tests
TECHBIO-TECHNE CorpBiotechnologyMarket cap US$ 11,4BP/E 66,77
US$ 72,78+19,2%1YSince added +0,4%
A+- Groei en kasstroom
- Groeit sterk
- Business trend
- Versnellend
- Business quality
- Sterk
- Getting better
- Verbetert sterk
Revenue
US$ 1,2B+0,9%Profit
US$ 172M+120,5%Free cash flow
US$ 308,2M+37,6%Why it is here: Sells proteins, antibodies and diagnostic reagents to researchers
BRKRBRUKER CORPORATIONMedical devicesMarket cap US$ 9,5BGeen K/W (bedrijfsverlies)
US$ 62,41+47,5%1YSince added +11,0%
B- Groei en kasstroom
- Groeit sterk
- Business trend
- Vertragend
- Business quality
- Gemengd
- Getting better
- Gemengd
Revenue
US$ 3,5B+2,2%Profit
US$ -123,4M-490,4%Free cash flow
US$ 244,7M+2.408,5%Why it is here: Makes scientific instruments for microscopy, spectroscopy and magnetic resonance research
RGENREPLIGEN CORPMedical instruments and suppliesMarket cap US$ 9,8BNo P/E
US$ 172,68+9,3%1YSince added -1,6%
B- Groei en kasstroom
- Groeit sterk
- Business trend
- Vertragend
- Business quality
- Gemengd
- Getting better
- Verbetert
Revenue
US$ 805,6M+13,8%Profit
US$ -11,8M-779,2%Free cash flow
US$ 106,7M-3,0%Why it is here: Supplies bioprocessing filtration, chromatography and protein products to biologic drug makers
BIOBIO-RAD LABORATORIES, INC.Medical devicesMarket cap US$ 10,4BGeen K/W (bedrijfsverlies)
US$ 386,08+18,0%1YSince added +6,1%
C- Groei en kasstroom
- Groeit
- Business trend
- Stabiel
- Business quality
- Solide
- Getting better
- Verbetert
Revenue
US$ 2,6B+1,4%Profit
US$ 1B+251,3%Free cash flow
US$ 329,1M-2,3%Why it is here: Sells life science research tools and clinical diagnostics reagents and instruments
QGENQIAGEN N.V.Diagnostics and researchMarket cap US$ 10,9BP/E 25,93
US$ 50,30+19,8%1YSince added +10,7%
B+- Groei en kasstroom
- Groeit sterk
- Business trend
- Stabiel
- Business quality
- Sterk
- Getting better
- Verbetert
Revenue
US$ 2,1B+2,1%Profit
US$ 384,5M-5,2%Free cash flow
US$ 436,2M-8,9%Why it is here: Supplies sample preparation and molecular testing kits and instruments
GHGUARDANT HEALTH, INC.Diagnostics and researchMarket cap US$ 20,9BGeen K/W (bedrijfsverlies)
US$ 154,76+58,2%1YSince added -4,5%
B- Groei en kasstroom
- Groeit sterk
- Business trend
- Stabiel
- Business quality
- Gemengd
- Getting better
- Gemengd
Revenue
US$ 1,3B+41,7%Profit
US$ -485,1M-21,6%Free cash flow
US$ -232,1M+11,5%Why it is here: Provides blood-based cancer diagnostic tests
MEDPMedpace Holdings, Inc.Diagnostics and researchMarket cap US$ 18,6BP/E 36,90
US$ 664,52+11,2%1YSince added +9,0%
C+- Groei en kasstroom
- Groeit sterk
- Business trend
- Vertragend
- Business quality
- Sterk
- Getting better
- Verbetert sterk
Revenue
US$ 2,8B+20,4%Profit
US$ 517,8M+19,6%Free cash flow
US$ 667,6M-1,4%Why it is here: Runs clinical trials for biotech and pharma drug developers
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.Diagnostics and researchMarket cap US$ 16,4BP/E 353,20
US$ 342,61+99,8%1YSince added +14,5%
F- Groei en kasstroom
- Gemengd
- Business trend
- Krimpend
- Business quality
- Gemengd
- Getting better
- Gemengd
Revenue
US$ 4B-1,2%Profit
US$ 40,2M+148,8%Free cash flow
US$ 399,6M-26,5%Why it is here: Provides preclinical research models and testing services to drug developers
Green and red compare each figure with the same window a year earlier. Grades and checks are the company page's own; nothing here is a recommendation.
Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.
DiscussionNo comments yet
Be civil and stick to the companies. Comments are opinions, not advice.